9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Toxicology of the Blood and Bone Marrow. Informa, London
2. 2010 Use of contact hypersensitivity in immunotoxicity testing. Humana Press, Totowa, NJ (2010) 598: 233-239.
3. 2010 Human Immunotoxicology: from Mechanisms and Animal Models to Man. John Wiley & Sons, Chichester
4. 2008 Bridging immunotoxicology to clinical drug development. John Wiley, New York (2008) p.375-384.
5. 2008 Safety assessment studies: Immunotoxicity. John Wiley & sons, New York (2008), p.269-322.
6. 2008 Autoimmunity and hypersensitivity. John Wiley, New York (2008), p.487-498.
7. 2007 Cytokines in Human Health: Immunotoxicology, Pathology and Therapeutic applications. Humana Press, Totowa, NJ
8. 2006 Role of immunotoxicology in assessing safety of drugs. Elsevier Publishing Co, New York (2006), p.809-816.
9. 2006 Paclitaxel associated hypersensitivity reactions. Assessment of the utility of a test dose program. The Cancer Journal (2006) 12, 237-245.
10. 2006 Principles and Methods for Assessing Autoimmunity associated with Exposure to Chemicals Environmental Health Criteria, Vol. 236. WHO, Geneva
11. 2006 Drugs acting on the immune system. Elsevier Sciences, Amsterdam (2006).
12. 2005 Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. Journal of Immunotoxicology (2005) 2, 11-20.
13. 2005 Immune response in human pathology: hypersensitivity and auto-immunity. Birkhäuser Verlag, Basel (2005), p.117-129.
14. 2004 Clinical and histopathological progression of renal and other changes in commercially obtained NZB x NZW kept under normal laboratory condition. Experimental and Toxicologic Pathology (2004) 56, 37-44.
15. 2004 Popliteal lymph node responses to ethanol and acetone differ from those induced by streptozotocin. Archives of Toxicology (2004) 78, 649-654.
16. 2004 Handbook of Non-Clinical Safety Testing WHO, Geneva
17. 2004 Immunotoxicology of Drugs and Chemicals. An Experimental and Clinical Approach: Principles and Methods of Immunotoxicology, Elsevier, Amsterdam
18. 2004 Cytokine release as an endpoint to improve the sensitivity and specificity of the direct PLNA. Toxicology (2004) 200, 247-254.
19. 2004 Autoimmunity, environmental exposure and vaccines: is there a link? Toxicology (2004) 196, 211-216.
20. 2004 Trichloroethylene does not accelerate autoimmune diabetes in NOD mice. Journal of Immunotoxicology (2004) 1, 141-148.
21. 2003 Tritiated thymidine incorporation does not enhance sensitivity of the popliteal lymph node assay Toxicology (2003) 188, 29-33.
22. 2003 Effects of two pediatric vaccines on autoimmune diabetes in NOD mice. Toxicology Letters (2003) 146, 93-100.
23. 2002 Effects of murine IL-2 in (NZB x NZW) F1 female mice. Immunopharmacology and Immunotoxicology (2002) 24, 409-421.
24. 2001 Compared effects of morphine and nickel chloride in vitro on NK cell activity in rats and monkeys Journal of Applied Toxicology (2001) 21, 431-434.
25. 2001 Positive responses to imipramine in the popliteal lymph node assay are due to primary irritation. Human and Experimental Toxicology (2001) 20, 591-596.
26. 2001 EosinophIlic fasciitis and simvastatin. Archives of Internal Medicine, 161, 1456-1457.
27. 2001 Occupational contact dermatitis to tetrazepam. Two case reports. Contact Dermatitis (2001) 44: 372.
28. 2001 Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites. Toxicology Letters (2001) 119, 183-192.
29. 2000 Increased production of gamma-interferon, but not Il-4 mRNA by streptozotocin in the popliteal lymph node assay Journal of Applied Toxicology (2000) 146, 73-82.
30. 2000 The popliteal lymph node response to streptozotocin is under type-1, MHC class-I restricted, CD8+ T-cell control. Toxicology (2000) 119, 183-192.
31. 2000 Drugs acting on the immune system. In: Meyler's Side-Effects of Drugs Elsevier, Amsterdam (2000), p. 1246-1337.
32. 1998 Clinical toxicity of the interferons. In: Biotechnology and Safety Assessment Raven Press, New York (1998), p.301-330.
33. 1998 Volatile Organic Compounds in the Environment, Risk Assessment and Neurotoxicity. Pavia University Press
34. 1998 An Introduction to Immunotoxicology. Taylor & Francis, London
35. 1997 The popliteal lymph node assay: results of a preliminary interlaboratory validation Toxicology (1997) 122, 213-218.
36. 1997 Drug-induced autoimmunity. Experience of the French Pharmacovigilance system. Toxicology (1997) 119, 23-27.
37. 1997 Autoantibodies in conventional toxicity testing. Toxicology (1997) 119, 51-58.
38. 1996 Human Toxicology. Elsevier, Amsterdam
39. 1996 Principles and Methods for Assessing Direct Immunotoxicity associated with Exposure to Chemicals. Environmental Health Criteria, Vol. 180, WHO, Geneva
40. 1996 Drugs acting on the immune system. In: Meyler s Side Effects of Drugs, 13th edition Elsevier, Amsterdam (1996) p.1090-1165.
41. 1996 Early indicators of immunotoxicity: development of molecular biological test batteries. Human and Experimental Toxicology (1996) 15, Suppl.1, 2-9.
42. 1995 The popliteal lymph node assay. In: Modern Methods in Immunotoxicology John Wiley & Sons, New York (1995) p.293-302.
43. 1995 Modelization of warning procedures to detect the toxic effects of drugs and chemicals to man: application to a sentinel disease programme in immunotoxicology. Toxicology Modelling (1995) 1, 207-218
44. 1995 Determination of lymphocyte subsets and cytokine levels in nonhuman primates: cross-reactivity of human reagents. Toxicology (1995) 105, 81-90.
45. 1994 Comparison of popliteal lymph node responses in various strains of rats Human and Experimental Toxicology (1994) 13, 455-460.
46. 1994 Anaphylaxis models in the guinea-pig. Toxicology (1994) 93, 55-61.
47. 1994 Prediction of drug-induced immediate hypersensitivity in guinea-pigs. Toxicology in vitro (1994) 8, 1045-1049.
48. 1994 Cytoreductive drugs. In: Immunopharmacology and Immunotoxicology, 2nd edition Raven Press, New-York (1994) p.293-301.
49. 1994 Morphology of popliteal lymph node responses in Brown-Norway rats. Journal of Toxicology and Environmental Health (1994) 41, 95-108.
50. 1994 Lymphocyte activation by liposome-trapped streptozotocin in murine popliteal lymph node (PLN) test. International Journal of Immunopharmacology (1994) 16, 817-824.
51. 1993 In vitro assessment of phagocytosis. Interspecies comparison of chemiluminescence response. Toxicology in vitro (1993) 7, 317-320.
52. 1992 Toxicological Emergencies Maloine, Paris
53. 1992 Introduction to Immunotoxicology Lacassagne, Lyon
54. 1992 Immunotoxicology of Immunomodulators. In: Standardization of the Immunopharmacology of Natural and Synthetic Immunomodulators, F. Brown & J.P. Revillard (eds). Karger, Basel (1992), p.99-102.
55. 1992 Immunomodulating agents. In: Meyler s Side-Effects of Drugs, 12th edition, M.N.G. Dukes ed. Elsevier, Amsterdam (1992) p.954-958.
56. 1992 Cefaclor-associated serum sickness-like disease: eight cases and review of the literature. The Annals of Pharmacotherapy (1992) 26, 910-914.
57. 1992 Popliteal lymph node response to procainamide and isoniazid. Role of ß-naphtoflavone, phenobarbitone and S-9 mix pre-treatment. Toxicology Letters (1992) 66, 21-28.
58. 1992 Changes in CD4+and CD8+ lymphocyte subsets by streptozotocin in murine popliteal lymph node (PLN) test. Journal of Autoimmunity (1992) 5, 183-197.
59. 1991 Immunotoxicity of bis(tributyltin)oxide in the rat. Journal of Toxicology and Environmental Health (1991) 32, 307-317.
60. 1991 Characterization of lymphocyte subsets in Cynomolgus monkeys using flow cytometry. Influence of methylprednisolone. Methods in Toxicology (1991) 1, 263-272.
61. 1990 Drug-Induced Immune Diseases. Elsevier, Amsterdam
62. 1990 functions in lead-exposed workers. Human and Experimental Toxicology (1990) 9, 231-233.
63. 1990 Applicability of the popliteal lymph node assay in Brown-Norway rats. Immunopharmacology and Immunotoxicology (1990) 12, 669-678.
64. 1989 Immune competence of valproate-treated mice. Immunopharmacology and Immunotoxicology (1989), 11, 593-602.
65. 1988 Elsevier, Amsterdam. Elsevier, Amsterdam.
66. 1988 Identification of contact allergens: the mouse ear sensitization assay. Journal of Toxicology - Cutaneous and Ocular Toxicology (1988) 7, 263-272
67. 1988 Enhancement of antibody response and delayed-type hypersensitivity by thalidomide in mice. Fundamental and Applied Pharmacology (1988) 2, 493-497.
68. 1988 Immunomodulating agents. In: Meyler's Side-Effects of Drugs, 11th edition, M.N.G. Dukes (ed.), Elsevier, Amsterdam (1988) p. 794-798.
69. 1987 Influence of tetanus and typhoid vaccines on hepatic drug metabolism. Pharmacology (1987) 36, 134-139.
70. 1987 Macrophage migration inhibition test to evaluate the sensitizing potential of drugs in the guinea-pig. Archives of Toxicology (1987) Suppl.11, 325-328.
71. 1987 Influence of heavy metals on the resistance of mice toward infection Immunopharmacology and Immunotoxicology (1987) 9, 235-242.
72. 1987 Polymorphonuclear leucocyte chemotaxis little affected by three quinolones in vitro. Journal of Antimicrobial Chemotherapy (1987) 4, 614-615.
73. 1986 Effects of josamycin on polymorphonuclear leukocyte chemotaxis Journal of Antimicrobial Chemotherapy (1986) 17, 763-766.
74. 1985 Miconazole influence on both cellular immune response and hepatic drug metabolism in mice. Journal of Immunopharmacology (1985) 7, 171-178.
75. 1985 Immunotoxicity screening of drugs and chemicals: value of contact hypersensitivity to picryl chloride in the mouse Methods and Findings in Experimental and Clinical Pharmacology (1985) 7, 303-305.
76. 1985 Increased paraquat plasma levels in intoxicated mice following anti-paraquat F(ab')2 treatment. Journal of Immunopharmacology (1985) 7, 467-477.
77. 1985 Influence of several bacterial and viral vaccines on hepatic drug metabolism Methods and Findings in Experimental and Clinical Pharmacology (1985) 7, 481-483.
78. 1985 Differential effects of several psychotropic agents on delayed hypersensitivity response in mice. Journal of Neuroimmunology (1985) 9, 81-85.
79. 1984 J.Cl. Evreux: Immunomodulating agents. In: Meyler's Side-Effects of Drugs, 10th edition, M.N.G. Elsevier, Amsterdam (1984) p.711-714.
80. 1984 Influence of lead on hypersensitivity Journal of Immunopharmacology (1984) 6, 87-93.
81. 1984 Comparative effects of various lead salts on delayed hypersensitivity Comparative effects of various lead salts on delayed hypersensitivity
82. 1983 Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicology letters (1983) 16, 281-284.
83. 1983 Effects of cimetidine and ranitidine on delayed type hypersensitivity. Effects of cimetidine and ranitidine on delayed type hypersensitivity.
84. 1983 Assessment of the allergenic potential of althesin and its constituents. British Journal of Anaesthesia (1983) 55, 515-717.
85. 1983 Hypersensitivity to Althesin infusion: measurement of complement involvement. Anaesthesia (1983) 38, 1079-1081.
86. 1983 Adjuvancy of Cremophor El° in rodents International Archives of Allergy and Clinical Immunology (1983) 72, 287-288.
87. 1983 Effects of variations in time and dose of diazepam injection on delayed hypersensitivity. Journal of Immunopharmacology (1983) 4, 279-284.
88. 1982 Suppression of humoral and cellular immunity in normal mice by diazepam. Immunology letters (1982) 5, 41-43.
89. 1982 Effect of chlorpromazine on contact hypersensitivity to DNCB in the guinea-pig. Journal of Neuroimmunology (1982) 2, 21-25.
90. 1981 Depressant effects of major tranquilizers on contact hypersensitivity to picryl chloride in the mouse Experientia (1981) 37, 1004-1005.
91. 1981 Immunological protection against ajmaline toxicity. Immunological protection against ajmaline toxicity.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.